Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Menopause01:28

Menopause

5.0K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.0K
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

2.4K
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
2.4K
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.5K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.5K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.2K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus-led recommendations supporting choice and personalisation of Hormone replacement therapy in menopause care.

Post reproductive health·2022
Same author

Consensus statement for non-hormonal based treatments for menopausal symptoms.

Post reproductive health·2020
Same author

Prescribing for Women with Breast Cancer in Their Survivorship Phase for Menopausal Symptoms.

European journal of breast health·2020
Same author

Getting underneath the skin: A community engagement event for optimal vitamin D status in an 'easily overlooked' group.

Health expectations : an international journal of public participation in health care and health policy·2019
Same author

Consensus statement for non-hormonal-based treatments for menopausal symptoms.

Post reproductive health·2017
Same author

A qualitative evaluation to explore the suitability, feasibility and acceptability of using a 'celebration card' intervention in primary care to improve the uptake of childhood vaccinations.

BMC family practice·2016

Related Experiment Video

Updated: Apr 28, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K

Consensus statement for non-estrogen-based treatments for menopausal symptoms.

Jane Woyka1, Nuttan Tanna2

  • 1GP Associate Specialist, The Northwick Park Menopause Clinical & Research Unit, North West London Hospitals NHS Trust, Middlesex, UK GP Partner, The Harrow Health Care Centre, Clementine Churchill Hospital, Middlesex, UK jw@harrowhealthcare.co.uk.

Post Reproductive Health
|June 1, 2014
PubMed
Summary

Non-estrogen therapies offer effective relief for menopausal symptoms like hot flashes and vaginal dryness, especially for cancer survivors. Personalized treatment ensures optimal outcomes for women

Keywords:
Breast cancermenopausenon-hormonal therapiessexual desireurogenital atrophy

More Related Videos

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.4K

Related Experiment Videos

Last Updated: Apr 28, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

11.7K
Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.2K
Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis
05:36

Herbs-Partitioned Moxibustion on the Navel in a Rat Model of Primary Dysmenorrhea with Cold Coagulation and Blood Stasis

Published on: October 4, 2024

1.4K

Area of Science:

  • Reproductive Medicine
  • Oncology
  • Women's Health

Background:

  • Menopausal symptoms such as hot flashes and urogenital atrophy significantly impact quality of life.
  • Estrogen-based therapies are common but contraindicated in certain conditions.
  • Alternative treatments are needed for women unable to use or not responding to estrogen therapy.

Purpose of the Study:

  • To review non-estrogen-based therapeutic options for menopausal symptoms.
  • To highlight the suitability of non-hormonal treatments for specific patient populations, including cancer survivors.

Main Methods:

  • Literature review of non-estrogen-based therapies for menopausal symptoms.
  • Analysis of treatment efficacy and safety profiles.
  • Consideration of patient-specific factors in treatment selection.

Main Results:

  • Non-estrogen therapies effectively manage hot flashes and urogenital atrophy.
  • These therapies address sexual dysfunction and fatigue unresponsive to estrogen.
  • Non-hormonal options are crucial for women with estrogen-sensitive cancers (e.g., breast, endometrial).

Conclusions:

  • Non-estrogen-based therapies provide viable alternatives for managing menopausal symptoms.
  • Individualized treatment selection is key for optimal patient outcomes.
  • Non-hormonal approaches are essential for women with contraindications to estrogen therapy, particularly cancer patients.